The FDA has authorized the Lucira COVID-19 All-In-One Test Kit -- the first coronavirus diagnostic for self-testing at home and that provides rapid results.
Vitalograph’s next generation In2itive e-Diary combines in-clinic spirometry, home monitoring of respiratory endpoints, and eCOA data gathering functions in a robust, handheld medical device.Read More
The FDA authorized a Quest Diagnostics COVID-19 test for “pooled” samples, allowing four people to be tested with one assay.Read More
The US FDA has authorized the BD Veritor Plus SARS-CoV-2 assay, a rapid, point-of-care, antigen test manufactured by Becton Dickinson.Read More
Scientists warn that reusable bronchoscopes used for COVID-19 patients could spread microbes and be a risk to patients and healthcare workers alike.Read More
The US FDA revoked the emergency use authorization of the DPP COVID-19 IgM/IgG System, a SARS-CoV-2 antibody test from Chembio Diagnostic System Inc, due to performance concerns with the accuracy of the test.Read More
The US FDA issued an emergency use authorization for the Illumina COVIDSeq Test, the first COVID-19 diagnostic test utilizing next generation sequence technology.Read More
The CDC is seeking emergency use authorization for a new diagnostic test that can simultaneously detect the SARS-CoV-2 coronavirus and the influenza virus.Read More